» Articles » PMID: 21242461

Creation and Characterization of a Renin Knockout Rat

Overview
Journal Hypertension
Date 2011 Jan 19
PMID 21242461
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

The renin-angiotensin system plays an important role in the control of blood pressure (BP) and renal function. To illuminate the importance of renin in the context of a disease background in vivo, we used zinc-finger nucleases (ZFNs) designed to target the renin gene and create a renin knockout in the SS/JrHsdMcwi (SS) rat. ZFN against renin caused a 10-bp deletion in exon 5, resulting in a frameshift mutation. Plasma renin activity was undetectable in the Ren-/- rat, and renin protein was absent from the juxtaglomerular cells in the kidney. Body weight was lower in the Ren-/- rats (than in the Ren+/- or wild-type littermates), and conscious BP on low-salt diet (0.4% NaCl) was 58 ± 2 mm Hg in the Ren-/- male rats versus 117 mm Hg in the Ren+/- littermates, a reduction of almost 50 mm Hg. Blood urea nitrogen (BUN) and plasma creatinine levels were elevated in the Ren-/- strain (BUN 112 ± 7 versus 23 ± 2 mg/dL and creatinine 0.53 ± 0.02 versus 0.26 ± 0.02 mg/dL), and kidney morphology was abnormal with a rudimentary inner renal medulla, cortical interstitial fibrosis, thickening of arterial walls, and abnormally shaped glomeruli. The development of the first rat knockout in the renin-angiotensin system demonstrates the efficacy of the ZFN technology for creating knockout rats for cardiovascular disease on any genetic background and emphasizes the role of renin in BP regulation and kidney function even in the low-renin SS rat.

Citing Articles

Pathophysiology and genetics of salt-sensitive hypertension.

Maaliki D, Itani M, Itani H Front Physiol. 2022; 13:1001434.

PMID: 36176775 PMC: 9513236. DOI: 10.3389/fphys.2022.1001434.


Genetic Modifications to Alter Blood Pressure Level.

Ohara H, Nabika T Biomedicines. 2022; 10(8).

PMID: 36009402 PMC: 9405136. DOI: 10.3390/biomedicines10081855.


Genetic Kidney Diseases (GKDs) Modeling Using Genome Editing Technologies.

Gomez-Garcia F, Martinez-Pulleiro R, Carrera N, Allegue C, Garcia-Gonzalez M Cells. 2022; 11(9).

PMID: 35563876 PMC: 9105797. DOI: 10.3390/cells11091571.


Recent Advances in the Production of Genome-Edited Rats.

Sato M, Nakamura S, Inada E, Takabayashi S Int J Mol Sci. 2022; 23(5).

PMID: 35269691 PMC: 8910656. DOI: 10.3390/ijms23052548.


Advances in Genome Editing and Application to the Generation of Genetically Modified Rat Models.

Chenouard V, Remy S, Tesson L, Menoret S, Ouisse L, Cherifi Y Front Genet. 2021; 12:615491.

PMID: 33959146 PMC: 8093876. DOI: 10.3389/fgene.2021.615491.


References
1.
Davisson R, Kim H, Krege J, Lager D, SMITHIES O, Sigmund C . Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes. J Clin Invest. 1997; 99(6):1258-64. PMC: 507940. DOI: 10.1172/JCI119283. View

2.
Wake R, Kim-Mitsuyama S, Izumi Y, Yoshida K, Izumiya Y, Yukimura T . Beneficial effect of candesartan on rat diastolic heart failure. J Pharmacol Sci. 2005; 98(4):372-9. DOI: 10.1254/jphs.fp0050160. View

3.
Pentz E, Moyano M, Thornhill B, Lopez M, Gomez R . Ablation of renin-expressing juxtaglomerular cells results in a distinct kidney phenotype. Am J Physiol Regul Integr Comp Physiol. 2003; 286(3):R474-83. DOI: 10.1152/ajpregu.00426.2003. View

4.
Sakata Y, Masuyama T, Yamamoto K, Doi R, Mano T, Kuzuya T . Renin angiotensin system-dependent hypertrophy as a contributor to heart failure in hypertensive rats: different characteristics from renin angiotensin system-independent hypertrophy. J Am Coll Cardiol. 2001; 37(1):293-9. DOI: 10.1016/s0735-1097(00)01064-0. View

5.
Meyer M, de Angelis M, Wurst W, Kuhn R . Gene targeting by homologous recombination in mouse zygotes mediated by zinc-finger nucleases. Proc Natl Acad Sci U S A. 2010; 107(34):15022-6. PMC: 2930558. DOI: 10.1073/pnas.1009424107. View